650 related articles for article (PubMed ID: 34256103)
1. Building and behavior of a pH-stimuli responsive chitosan nanoparticles loaded with folic acid conjugated gemcitabine silver colloids in MDA-MB-453 metastatic breast cancer cell line and pharmacokinetics in rats.
Karuppaiah A; Babu D; Selvaraj D; Natrajan T; Rajan R; Gautam M; Ranganathan H; Siram K; Nesamony J; Sankar V
Eur J Pharm Sci; 2021 Oct; 165():105938. PubMed ID: 34256103
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and Characterization of Folic Acid Conjugated Gemcitabine Tethered Silver Nanoparticles (FA-GEM-AgNPs) for Targeted Delivery.
Karuppaiah A; Rajan R; Hariharan S; Balasubramaniam DK; Gregory M; Sankar V
Curr Pharm Des; 2020; 26(26):3141-3146. PubMed ID: 32175835
[TBL] [Abstract][Full Text] [Related]
3. Co-delivery of docetaxel and gemcitabine by anacardic acid modified self-assembled albumin nanoparticles for effective breast cancer management.
Kushwah V; Katiyar SS; Dora CP; Kumar Agrawal A; Lamprou DA; Gupta RC; Jain S
Acta Biomater; 2018 Jun; 73():424-436. PubMed ID: 29649635
[TBL] [Abstract][Full Text] [Related]
4. Development and characterization of folic acid-conjugated chitosan nanoparticles for targeted and controlled delivery of gemcitabinein lung cancer therapeutics.
Wang F; Wang Y; Ma Q; Cao Y; Yu B
Artif Cells Nanomed Biotechnol; 2017 Dec; 45(8):1530-1538. PubMed ID: 27894196
[TBL] [Abstract][Full Text] [Related]
5. Sialic Acid Conjugated Chitosan Nanoparticles: Modulation to Target Tumour Cells and Therapeutic Opportunities.
Rana R; Rani S; Kumar V; Nakhate KT; Ajazuddin ; Gupta U
AAPS PharmSciTech; 2021 Dec; 23(1):10. PubMed ID: 34862568
[TBL] [Abstract][Full Text] [Related]
6. Thermo- and pH-responsive targeted lipid-coated mesoporous nano silica platform for dual delivery of paclitaxel and gemcitabine to overcome HER2-positive breast cancer.
Nasri N; Saharkhiz S; Dini G; Yousefnia S
Int J Pharm; 2023 Dec; 648():123606. PubMed ID: 37972671
[TBL] [Abstract][Full Text] [Related]
7. Nanotechnology improves the therapeutic efficacy of gemcitabine against a human hepatocellular carcinoma cell line and minimizes its in vivo side effects.
El-Sheikh SMA; Khairy MH; Osama E; Metwally MMM; Galal AAA
Naunyn Schmiedebergs Arch Pharmacol; 2021 Apr; 394(4):631-643. PubMed ID: 33104848
[TBL] [Abstract][Full Text] [Related]
8. Unraveling the Effect of Breast Cancer Patients' Plasma on the Targeting Ability of Folic Acid-Modified Chitosan Nanoparticles.
Nemati M; Bani F; Sepasi T; Zamiri RE; Rasmi Y; Kahroba H; Rahbarghazi R; Sadeghi MR; Wang Y; Zarebkohan A; Gao H
Mol Pharm; 2021 Dec; 18(12):4341-4353. PubMed ID: 34779630
[TBL] [Abstract][Full Text] [Related]
9. Anti-tumor efficacy of folate modified PLGA-based nanoparticles for the co-delivery of drugs in ovarian cancer.
Li S; Li X; Ding J; Han L; Guo X
Drug Des Devel Ther; 2019; 13():1271-1280. PubMed ID: 31114163
[No Abstract] [Full Text] [Related]
10. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
Bagre AP; Jain K; Jain NK
Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
[TBL] [Abstract][Full Text] [Related]
11. pH-responsive chitosan/acrylamide/gold/nanocomposite supported with silver nanoparticles for controlled release of anticancer drug.
Nasef SM; Khozemy EE; Mahmoud GA
Sci Rep; 2023 May; 13(1):7818. PubMed ID: 37188828
[TBL] [Abstract][Full Text] [Related]
12. Synergistic Nanocomposites of Different Antibiotics Coupled with Green Synthesized Chitosan-Based Silver Nanoparticles: Characterization, Antibacterial, in vivo Toxicological and Biodistribution Studies.
Asghar MA; Yousuf RI; Shoaib MH; Asghar MA; Ansar S; Zehravi M; Abdul Rehman A
Int J Nanomedicine; 2020; 15():7841-7859. PubMed ID: 33116504
[TBL] [Abstract][Full Text] [Related]
13. Chitosan-encapsulated nickel oxide, tin dioxide, and farnesol nanoparticles: Antimicrobial and anticancer properties in breast cancer cells.
Mickymaray S; Al Aboody MS; Eraqi MM; Alhoqail WA; Alothaim AS; Suresh K; Arulselvan P
Int J Biol Macromol; 2023 Sep; 248():125799. PubMed ID: 37451381
[TBL] [Abstract][Full Text] [Related]
14. Preparation and characterization of polyelectrolyte complex nanoparticles based on poly (malic acid), chitosan. A pH-dependent delivery system.
Arif M; Raja MA; Zeenat S; Chi Z; Liu C
J Biomater Sci Polym Ed; 2017 Jan; 28(1):50-62. PubMed ID: 27691398
[TBL] [Abstract][Full Text] [Related]
15. Development of Optimized, Inhalable, Gemcitabine-Loaded Gelatin Nanocarriers for Lung Cancer.
Youngren-Ortiz SR; Hill DB; Hoffmann PR; Morris KR; Barrett EG; Forest MG; Chougule MB
J Aerosol Med Pulm Drug Deliv; 2017 Oct; 30(5):299-321. PubMed ID: 28277892
[TBL] [Abstract][Full Text] [Related]
16. Gemcitabine delivered by fucoidan/chitosan nanoparticles presents increased toxicity over human breast cancer cells.
Oliveira C; Neves NM; Reis RL; Martins A; Silva TH
Nanomedicine (Lond); 2018 Aug; 13(16):2037-2050. PubMed ID: 30189774
[TBL] [Abstract][Full Text] [Related]
17. A Novel Delivery System of RGD-HSA Loaded GEM/CUR Nanoparticles for the Treatment of Pancreatic Cancer Therapy.
Ma T; Jiang JL; Qi WX; Chen JY; Xu HP
Drug Des Devel Ther; 2022; 16():2395-2406. PubMed ID: 35923931
[TBL] [Abstract][Full Text] [Related]
18. Gemcitabine cationic polymeric nanoparticles against ovarian cancer: formulation, characterization, and targeted drug delivery.
Bhattacharya S; Anjum MM; Patel KK
Drug Deliv; 2022 Dec; 29(1):1060-1074. PubMed ID: 35363113
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxicity Enhancement of α-Mangostin with Folate-Conjugated Chitosan Nanoparticles in MCF-7 Breast Cancer Cells.
Herdiana Y; Wathoni N; Shamsuddin S; Muchtaridi M
Molecules; 2023 Nov; 28(22):. PubMed ID: 38005306
[TBL] [Abstract][Full Text] [Related]
20. Fabrication and assessment of folic acid conjugated-chitosan modified PLGA nanoparticle for delivery of alpha terpineol in colon cancer.
Rahmati A; Homayouni Tabrizi M; Karimi E; Zarei B
J Biomater Sci Polym Ed; 2022 Jul; 33(10):1289-1307. PubMed ID: 35260045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
